Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer. J Clin Pathol 2001; 54: 669–74., , .
AIDS-related malignancies. Nat Rev Cancer 2002; 2: 373–82., .
Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (IARC Press, Lyon, 2001)., International Agency for Research on Cancer.
Mechanisms of spontaneous human cancers. Environ Health Perspect 1996; 104 (Suppl 3): 633–7..
Roitt's Essential Immunology (Blackwell Science, Malden, MA, 2001)., .
Immunology (Freeman, New York, 2003)..
The Immune System (Garland Publishing, New York, 2000)..
DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe?Clin Sci (Lond) 2003; 104: 437–46..
Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997; 90: 3245–87..
Robbins Pathologic Basis of Disease (Saunders, Philadelphia, 1999)., , , .
Identification and isolation of CD1a positive putative tumour infiltrating dendritic cells in human breast cancer. Adv Exp Med Biol 1997; 417: 571–7., , , , .
Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells. Hum Immunol 2002; 63: 1149–55., .
Dendritic cells as targets for cytotoxic T lymphocytes. Adv Exp Med Biol 1997; 417: 389–94., , .
The biology of human natural killer-cell subsets. Trends Immunol 2001; 22: 633–40., , .
Immunohistochemical detection of eosinophilic infiltration in pulmonary adenocarcinoma. Anticancer Res 2002; 22: 2391–6., , .
The central role of CD4(+) T-cells in the antitumor immune response. J Exp Med 1998; 188: 2357–68., , et al.
CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics. Eur J Immunol 2000; 30: 1872–83., , .
Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: in situ expression of mannose receptor by selected macrophages, endothelial cells, perivascular microglia, and mesangial cells, but not dendritic cells. J Exp Med 1999; 189: 1961–72., , , .
Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002; 2: 773–86., .
Altered expression of mast cell chymase and tryptase and of c-Kit in human cutaneous scar tissue. J Invest Dermatol 2000; 114: 51–5., , et al.
Mast cell-tumor cell interactions: for or against tumour growth and metastasis?Anticancer Res 1997; 17: 1541–9., .
The danger model: a renewed sense of self. Science 2002; 296: 301–5..
C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2002; 2: 77–84., , .
Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance. J Exp Med 2002; 195: 423–35., , et al.
The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992; 13: 11–16.
TLR2: cellular sensor for microbial and endogenous molecular pattrns. Curr Top Microbiol Immunol 2002; 270: 121–44., .
Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002; 195: 99–111.et al.
Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 2000; 12: 1539–46., , , , .
Is cancer dangerous to the immune system?Semin Immunol 1996; 8: 271–80., .
Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 1995; 92: 11810–13., , et al.
Progress in the development of immunotherapy for the treatment of patients with cancer. J Intern Med 2001; 250: 462–75..
Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses. Nat Rev Cancer 2002; 2: 409–19., .
Prostate stem cell antigen: identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patients. Int J Cancer 2002; 102: 390–7., , et al.
Identifying immunotherapeutic targets for prostate carcinoma through the analysis of gene expression profiles. Ann NY Acad Sci 2002; 975: 232–46..
Electrospray mass spectrometry for the identification of MHC class I-associated peptides expressed on cancer cells. J Immunol Methods 2002; 262: 5–19., , , , .
Analysis of the B-cell repertoire against antigens expressed by human neoplasms. Immunol Rev 2002; 188: 43–50., , , , .
Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytes. J Immunol 1996; 157: 3030–8., , et al.
Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines. Haematologica 2002; 87: 989–1001., , , .
Gastrointestinal stromal tumors. Curr Treat Options Oncol 2001; 2: 485–91., , .
Antitumor vaccination using peptide based vaccines. Immunol Lett 2000; 74: 27–34., , .
Immune intervention against virus-associated human cancers. Ann Oncol 1995; 6(Suppl 1): 69–71..
Tumor-infiltrating B-cell-derived IgG recognizes tumor components in human lung cancer. Cancer Invest 2000; 18: 530–6., , et al.
Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer. Cancer Res 2001; 61: 7889–99.et al.
Immunoglobulin genes expressed by B-lymphocytes infiltrating cervical carcinomas show evidence of antigen-driven selection. Cancer Immunol Immunother 2001; 50: 523–32., , et al.
Survival in human colorectal cancer correlates with expression of the T-cell costimulatory molecule OX-40 (CD134). Am J Surg 2002; 183: 512–18., , , , .
Tumour-infiltrating lymphocytes in non-small cell lung cancer are activated T lymphocytes. Respirology 1998; 3: 55–9., , , , .
Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance. Mod Pathol 1993; 6: 721–8., , et al.
Growth of tumor-infiltrating lymphocytes from human solid cancers: summary of a 5-year experience. Int J Cancer 1996; 65: 413–21.et al.
Histocompatibility leukocyte antigen-A2-restricted and tumor-specific cytotoxic T lymphocytes from tumor-infiltrating lymphocytes of patient with testicular embryonal cancer. Jpn J Cancer Res 1997; 88: 1181–9., , , , .
Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC Class II-restricted fashion. Cancer J Sci Am 1996; 2: 263., , et al.
Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 1994; 12: 337–65., , , , .
Human CD4+ T-cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene. Proc Natl Acad Sci USA 1994; 91: 9461–5., , et al.
Critical role for CD4(+) T-cells in controlling retrovirus replication and spread in persistently infected mice. J Virol 1998; 72: 6559–64., , .
Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002; 3: 991–8., , , , .
CD4+ tumor-infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papillomavirus-E7. J Immunol 1999; 163: 5715–22., , et al.
Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J Exp Med 2002; 196: 129–34., , , .
MHC Class II-restricted tumor antigens recognized by CD4+ T cells: new strategies for cancer vaccine design. J Immunother 2001; 24: 195–204..
Natural selection of tumor variants in the generation of “tumor escape” phenotypes. Nat Immunol 2002; 3: 999–1005., .
Antigen presentation of a modified tumor-derived peptide by tumor infiltrating lymphocytes. Cell Immunol 2001; 214: 139–44., , , ,
HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2. Cell Immunol 1996; 174: 116–28., , et al.
Interleukin-12 augments the generation of autologous tumor-reactive CD8+ cytotoxic T lymphocytes from tumor-infiltrating lymphocytes. Jpn J Cancer Res 1995; 86: 135–9.et al.
Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. Cancer Res 1991; 51: 6153–62., , , , .
Adoptive transfer of cytotoxic T lymphocytes induced by CD86-transfected tumor cells suppresses multi-organ metastases of C1300 neuroblastoma in mice. Cancer Immunol Immunother 1997; 44: 204–10., , , .
Importance of cytotoxic T lymphocytes in the rejection of transplanted hepatocellular carcinoma. J Gastroenterol 1994; 29: 282–8., , et al.
Selective MHC expression in tumours modulates adaptive and innate antitumour responses. Cancer Immunol Immunother 1999; 48: 374–81., .
Human gammadelta T cells: a nonredundant system in the immune-surveillance against cancer. Trends Immunol 2002; 23: 14–18., , , , .
Characterization of tumor-infiltrating lymphocytes derived from human tumors for use as adoptive immunotherapy of cancer. J Immunother 1997; 20: 377–86., , , .
Phenotypic and functional characterisation of tumour-infiltrating lymphocytes derived from thyroid tumours. Eur J Cancer 1996; 32A: 1233–9., , et al.
Tumour-infiltrating lymphocytes mediate lysis of autologous squamous cell carcinomas of the head and neck. Cancer Immunol Immunother 1995; 41: 243–50., , .
Isolation and characterization of tumor-infiltrating lymphocytes from cervical carcinoma. Int J Cancer 1994; 57: 805–13., , , , .
Proliferation, phenotype, and cytotoxicity of human lymphocytes isolated from lymph nodes invaded by melanoma cells. Hybridoma 1994; 13: 241–6., , et al.
Lymphokine-activated killer cell activity of peripheral blood, spleen, regional lymph node, and tumor infiltrating lymphocytes in gastric cancer patients. J Surg Oncol 1994; 55: 179–85., , et al.
Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area. Gut 1994; 35: 382–7., , , .
Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma: sequential proliferation of cytotoxic natural killer and noncytotoxic T-cells in RCC. J Immunother 1991; 10: 313–25., , et al.
Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts. J Immunol 1998; 140: 671–8., , et al.
Characterization of a chemically induced tumor model and the effects of natural killer cell depletion by antiasialo GM-1. Immunobiology 1994; 190: 333–45., , .
Immature myeloid cells and cancer-associated immune suppression. Cancer Immunol Immunother 2002; 51: 293–8., .
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 2001; 7: 1339–46., , et al.
Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions. Eur J Immunol 2003; 33: 1052–62., , et al.
Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 81: 1893–904., , et al.
Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996; 77: 1303–10., , et al.
Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas. Clin Cancer Res 1997; 3: 817–19., , et al.
The implementation of guidelines and computerised forms improves the completeness of cancer pathology reporting. The CROPS project: a randomised controlled trial in pathology. Eur J Cancer 2002; 38: 764–72., , et al.
Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T-cells. World J Surg 1995; 19: 352–8., , , , .
Evidence that regression in keratoacanthoma is immunologically mediated: a comparison with squamous cell carcinoma. Br J Dermatol 1994; 131: 789–98., , , .
Prognostic significance of simultaneous infiltration of HLA-DR-positive dendritic cells and tumor infiltrating lymphocytes into human esophageal carcinoma. Tohoku J Exp Med 1993; 169: 187–95., , et al.
CD3-zetachain expression of intratumoral lymphocytes is closely related to survival in gastric carcinoma patients. Cancer 2002; 94: 1437–42., , et al.
Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. Oncol Rep 2003; 10: 309–13., , et al.
Prostatic carcinoma: some morphological features affecting prognosis. Cancer 1976; 37: 2455–65., .
Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer 1994; 30A, 1797–803., , , .
Lymphoepithelioma of the oropharynx. Otolaryngol Head Neck Surg 1989; 100: 303–7., , .
Palatal lymphoepitheliomas and a review of head and neck lymphoepitheliomas. Clin Radiol 1999; 54: 289–93., , , , .
Systemic and local immunosuppression in pancreatic cancer patients. Clin Cancer Res 2001; 7: 925s–32s., , .
Clemente CG, Cascinelli N. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. Lab Invest 1996; 74: 43–7.,
Prophylactic cancer vaccines. Curr Opin Immunol 2002; 14: 172–7., .
A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347: 1645–51.et al.
The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 2003; 15: 138–47., , .
Spinning molecular immunology into successful immunotherapy. Nat Rev Immunol 2002; 2: 227–38..
Improvement of adoptive cellular immunotherapy of human cancer using ex-vivo gene transfer. Curr Gene Ther 2002; 2: 91–100., , .
Cancer vaccines: progress reveals new complexities. J Clin Invest 2002; 110: 289–94., .
Urinary cytokines reflecting the immunological response in the urinary bladder to biological response modifiers: their practical use. Eur Urol 2000; 37(Suppl 3): 16–23., , , .
Improving the efficacy of antibody-based cancer therapies. Nat Rev Cancer 2001; 1: 118–29..
Multiple pathways to tumor immunity and concomitant autoimmunity. Immunol Rev 2002; 188: 122–35., , , , .
The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer 2002; 87: 301–8., , et al.
Epidemiology of AIDS-related malignancies an international perspective. Hematol Oncol Clin North Am 2003; 17: 673–96, v., , .
The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 2000; 27: 390–401..
MAGE-1 and MAGE-3 or -6 expression in neuroblastoma-related pediatric solid tumors. Int J Cancer 1996; 69: 375–80., , et al.
Clinical cancer vaccine trials. Curr Opin Immunol 2002; 14: 178–82., , .
Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma. Cancer Res 1998; 58: 5344–7., , , .
The effect of lymphocytic infiltration on clinical survival in cancer of the tongue. Eur Arch Otorhinolaryngol 1994; 251: 366–9., , , .
Lymphocyte-rich gastric cancer: associations with Epstein–Barr virus, microsatellite instability, histology, and survival. Mod Pathol 2003; 16: 641–51., , , , .
Lymphoepithelioma-like carcinoma of the stomach: a subset of gastric carcinoma with distinct clinicopathological features and high prevalence of Epstein–Barr virus infection. Hepatogastroenterology 1999; 46: 1214–19., , et al.
Prognostic significances of tumor-infiltrating S-100 positive dendritic cells and lymphocytes in patients with hepatocellular carcinoma. Hepatogastroenterology 2003 Sep–Oct; 50(53): 1281–4., , , , .
Pathology of hereditary nonpolyposis colorectal cancer. Ann NY Acad Sci 2000; 910: 62–73; discussion 73–4..
Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status. Gut 2001; 48: 360–6., , et al.
The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 1997; 79: 2320–8., , et al.
Infiltration of CD8+ T-cells in non-small cell lung cancer is associated with dedifferentiation of cancer cells, but not with prognosis. Tohoku J Exp Med 2000; 191: 113–18., , et al.
Infiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: no association with prognosis identified in 3-year follow-up. Int J Cancer 2003; 103: 408–12., , et al.
A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma. Clin Cancer Res 2000; 6: 1875–81., , .
Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung Cancer 2002; 35: 23–8., , et al.
The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma. J Thorac Cardiovasc Surg 2001; 121: 1058–63., , .
Tumour infiltrating lymphocytes in relation to tumour angiogenesis, apoptosis and prognosis in patients with large cell lung carcinoma. Lung Cancer 1999; 26: 73–83., , .
S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Pathology 1993; 25: 338–43., .
Lymphoepithelioma-like carcinoma of the lung with a better prognosis. A clinicopathologic study of 32 cases. Am J Clin Pathol 2001; 115: 841–50., , , .
Histologic correlates of virulence in ovarian adenocarcinoma. II. Morphologic correlates of host response. Am J Obstet Gynecol 1982; 144: 885–9., , .
The significance of local cellular immune response of women 50 years of age and younger with endometrial carcinoma. Eur J Gynaecol Oncol 2002; 23: 243–6., , et al.
Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: a prognostic study. Pathology 1996; 28: 321–7., , , .
Significance of lymphoplasmocytic infiltration around tumor cell in the prediction of regional lymph node metastases in patients with invasive squamous cell carcinoma of the vulva: a clinicopathologic study. Gynecol Oncol 1989; 34: 200–5., , , .
Testicular seminoma: histological findings and their prognostic significance for stage II disease. J Surg Oncol 1987; 36: 166–9., , , .
The relationships among tumor-infiltrating lymphocytes, histopathologic findings, and long-term clinical follow-up in renal cell carcinoma. Mod Pathol 1992; 5: 420–5., , , , .
Prognostic significance of histopathological findings (including lymphocyte infiltration) in renal cell carcinoma. Hinyokika Kiyo 1996; 42: 925–30., , et al.
Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer. Eur J Cancer 1992; 29A: 69–75., , , , .
Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas. Cancer Res 2003; 63: 3275–80., , .
The identification of informative parameters in the flow cytometric analysis of breast carcinoma. Eur J Cancer 1993; 29A: 719–23., , , .
Prognostic significance of T-cell infiltrates, expression of beta 2-microglobulin and HLA-DR antigens in breast carcinoma. Pathol Res Pract 1994; 190: 1134–40., , .
Tumour-associated eosinophilia: a review. J Clin Pathol 1981; 34: 1343–8., , .
HER2 as a prognostic factor in breast cancer. Oncology 2001; 61(Suppl 2): 67–72., , , , .
Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells?J Cell Biochem 1990; 44: 189–98., , et al.
The mononuclear cell infiltrate compared with survival in high-grade astrocytomas. Acta Neuropathol (Berl) 1989; 78: 189–93., , et al.
Oligodendroglioma. Histologic evaluation and prognosis. J Neuropathol Exp Neurol 1986; 45: 65–78., , , .
Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 1978; 4: 219–24., , , .
Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases. J Neurosurg 1978; 49: 854–61., , .
Lymphocytic infiltration in long-survival glioblastomas: possible host's resistance. Acta Neurochir (Wien) 1977; 39: 27–33., , .
Presence and significance of NK cells in glioblastomas. J Neurosurg 1989; 70: 728–31., , et al.